EVALUATION OF THE FUNCTIONAL PROPERTIES OF A BIOLOGICAL CASE FOR IMPLANTABLE CARDIAC DEVICES, IMPREGNATED WITH BIOACTIVE SUBSTANCES IN AN EXPERIMENT ON LARGE LABORATORY ANIMALS
Open Access
- 11 July 2019
- journal article
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 34 (2)
Abstract
Aim. The purpose of the experimental study was to determine the functional properties of the case with antibacterial and hemostatic preparations impregnated on it, to assess the biological safety and the effectiveness of using this medical device in an in vivo model on large laboratory animals (pigs).Material and Methods. The article presents the first results of an experimental study of a domestic extracellular collagen matrix-based biological case “Bio-NEST” for implantable cardiac devices, impregnated with bioactive substances, in an in vivo experiment on large laboratory animals. The experiment was conducted in three chronological stages to analyze and evaluate the safety, efficacy, and histological compatibility of the biological sheath during implantation and reimplantation of cardiac devices using bioactive substances (antibacterial, hemostatic, and their combinations) as well as under the conditions of the established model of infection with pathogenic microflora implant pocket.Results. Results of the study showed that the use of the experimental cover sample was safe for a laboratory animal. Experimental samples were biocompatible and did not cause inflammatory and immune responses. Implantation of cardiac devices in the sample of the case allowed preventing implant migration and development of infectious inflammation of the implant bed when the experimental cover was impregnated with a solution of rifampicin and aminocaproic acid.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy of a Bio‐Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High‐Risk SubjectsJournal of Cardiovascular Electrophysiology, 2015
- Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device ImplantationJournal of Cardiovascular Electrophysiology, 2015
- Rates of and Factors Associated With Infection in 200 909 Medicare Implantable Cardioverter-Defibrillator ImplantsCirculation, 2014
- Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac DevicesJAMA, 2012
- Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort studyHeart, 2012
- Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infectionsHeart Rhythm, 2011
- Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial EnvelopePacing and Clinical Electrophysiology, 2010
- Update on Cardiovascular Implantable Electronic Device Infections and Their ManagementCirculation, 2010
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesJACC, 2008
- Implantable Cardioverter-DefibrillatorsJAMA, 2006